Alivus Life Sciences Financials

NSE: GLS | BSE: 543322

₹1,497.20

up-down-arrow ₹-23.50 (-1.55%)

As on 05-Nov-2026IST

Market cap

info icon

₹18,411 Cr

Revenue (TTM)

info icon

₹2,684 Cr

P/E Ratio

info icon

27.5

P/B Ratio

info icon

5.1

Div. Yield

info icon

0.3 %

Income Statement (₹ Cr)

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Operating Revenue
2,684.41
2,551.83
2,386.88
2,283.21
2,161.22
2,123.21
Total Income
2,763.43
2,612.24
2,421.45
2,295.26
2,190.18
2,137.92
Total Expenditure
1,761.70
1,754.55
1,704.30
1,608.97
1,518.93
1,507.15
EBITDA
922.70
797.28
682.58
674.25
642.29
616.06
Depreciation
82.27
75.36
60.61
53.45
42.09
37.88
EBIT
840.44
721.93
621.98
620.79
600.20
578.18
Interest
5.42
5.37
2.41
1.55
0.55
27.96
Other Income
79.02
60.41
34.57
12.04
28.96
14.70
Exceptional Items
-25.66
-25.66
--
--
--
--
Profit before Tax
888.39
751.31
654.13
631.29
628.61
564.93
Provision for Tax
218.65
186.83
168.50
160.40
161.65
146.20
Profit after Tax
669.74
564.48
485.63
470.89
466.96
418.72

Liabilities (₹ Cr)

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Shareholder's Funds
3,631.29
3,332.13
2,817.37
2,332.32
2,138.21
2,054.31
Minority Interest
--
--
--
--
--
--
Non-Current Liabilities
146.95
142.73
466.05
756.95
67.40
32.70
Current Liabilities
563.70
682.24
470.16
438.77
1,014.89
746.80
Total Liabilities
4,341.94
4,157.10
3,753.59
3,528.05
3,220.49
2,833.81

Assets (₹ Cr)

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Non-Current Assets
1,454.42
1,333.54
1,418.43
1,612.05
851.81
706.42
Current Assets
2,864.85
2,823.56
2,335.16
1,916.00
2,368.68
2,127.39
Total Assets
4,341.94
4,157.10
3,753.59
3,528.05
3,220.49
2,833.81
Total Debt*
--
--
--
--
--
--
Net Current Assets
2,301.15
2,141.33
1,865.00
1,477.23
1,353.80
1,380.59
Contingent Liabilities
--
4.82
4.82
4.82
2.22
2.22

Cashflow (₹ Cr)

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Cash From Operating Activities
--
565.41
391.52
413.52
306.01
597.59
Cash Flow from Investing Activities
--
-570.15
-615.65
-116.48
-146.75
-122.23
Cash from Financing Activities
--
-64.34
-6.23
-279.44
-387.59
-78.80
Net Cash Inflow / Outflow
--
-69.08
-230.35
17.59
-228.33
396.56

Financials Ratios

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Adjusted EPS (₹) info
56.15
45.99
39.63
38.43
38.11
34.17
Cash EPS (₹) info
54.47
52.13
44.58
42.79
41.55
37.27
Adjusted Book Value (₹) info
295.31
270.90
229.11
189.45
173.97
167.38
Dividend per Share (₹) info
0.33
5.00
5.00
22.50
21.00
21.00
Cash Flow per Share (₹) info
--
46.07
31.95
33.75
24.98
48.77
Free Cash Flow per Share (₹) info
--
16.64
16.30
21.33
10.82
34.63

Profitability Ratios

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
ROCE (%) info
--
24.61
25.50
28.31
30.01
42.24
ROE (%) info
19.79
18.41
18.94
21.15
22.33
29.87
ROA (%) info
16.78
14.27
13.34
13.96
15.43
16.57
EBIT Margin (%) info
31.31
28.29
26.06
27.19
27.77
27.23
Net Margin (%) info
24.24
21.61
20.06
20.52
21.32
19.59
Cash Profit Margin (%) info
--
24.81
22.79
22.90
23.43
21.48

Growth Ratios

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Revenue Growth (%) info
8.19
6.91
4.54
5.64
1.79
12.63
EBIT Growth (%) info
24.77
16.07
0.19
3.43
3.81
3.68
Net Profit Growth (%) info
29.94
16.24
3.13
0.84
11.52
19.10
EPS Growth (%) info
26.13
16.05
3.12
0.84
11.52
4.78
Book Value Growth (%) info
--
18.43
20.94
8.90
3.94
172.44

Valuation Ratios

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Price / Earnings info
27.49
21.18
27.24
20.17
10.28
13.43
Price / Book Value info
5.07
3.60
4.71
4.09
2.25
2.74
Dividend Yield (%) info
0.33
0.51
0.46
2.90
5.36
4.58
EV/EBITDA info
18.35
13.94
18.35
13.40
6.69
8.10
Close Price (₹) info
1,379.30
972.70
1,081.15
776.65
392.90
458.80
High Price (₹) info
1,495.30
1,225.10
1,335.10
906.00
534.00
799.95
Low Price (₹) info
819.00
819.00
743.60
375.95
369.00
376.00
Market Cap (₹ Cr) info
18,411.28
11,956.86
13,228.83
9,499.31
4,798.12
5,623.90

Solvency Ratios

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Debt to Equity info
--
--
--
--
--
--
Short term debt to equity ratio info
--
--
--
--
--
--
Current Ratio info
5.08
4.14
4.97
4.37
2.33
2.85
Quick Ratio info
3.69
3.12
3.53
2.85
1.74
2.16
Interest Coverage info
165.03
140.86
271.97
409.34
1,150.19
21.20

Operating Efficiency Ratios

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Debtors to sales (%) info
36.81
42.05
40.63
33.52
37.33
31.72
Asset Turnover info
0.67
0.65
0.66
0.68
0.72
0.84
Receivable days info
--
144.58
132.12
125.30
124.34
111.01
Inventory Days info
--
96.67
102.08
101.28
94.11
88.40
Payable days info
--
135.45
133.54
149.95
136.29
94.72
Cash Conversion Cycle info
--
105.80
100.66
76.63
82.16
104.69
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...

Mutual Fund Insight turns 24! 🎉 Get 2 FREE anniversary guides: The Right SIP + The Big Funds